Who is sponsoring NCT05712486?

NCT05712486 is sponsored by University of Valladolid.

What drugs are being tested in NCT05712486?

Interventions in NCT05712486: High force hip Lateral distraction, Placebo force hip lateral distraction.

What condition does NCT05712486 study?

NCT05712486 studies Osteitis Pubis.

Is NCT05712486 still recruiting?

NCT05712486 is currently completed. Last updated 25 March 2026.

Last reviewed 2026-03-25 · How we verify

NCT05712486

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Manual Therapy for the Treatment of Athletic Pubalgia

Completed NA Last updated 25 March 2026

What this trial tests

NA trial testing High force hip Lateral distraction in Osteitis Pubis in 36 participants. Completed in 30 October 2025.

Timeline

1 February 2023

Primary endpoint
30 October 2025

30 October 2025

Quick facts

Lead sponsor	University of Valladolid
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	36
Start date	1 February 2023
Primary completion	30 October 2025
Estimated completion	30 October 2025
Sites	1 location across Spain

Drugs / interventions tested

High force hip Lateral distraction
Placebo force hip lateral distraction

Conditions studied

Osteitis Pubis — all drugs for Osteitis Pubis →

Sponsor

University of Valladolid

Who can join

Adults 18 to 40, any sex, with Osteitis Pubis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Athletic osteitis pubis is a high prevalent pathology among athletes, especially in those who make quick change of direction of the movement, like runners or footballers. Despite the fact that there is evidence about conservative treatments, there is a lack of evidence about manual therapy (MT) techniques applied in isolation and its consequences in pain and range of movement. The investigators decided to conduct a randomized controlled trial to compare the effects of a MT technique with placebo technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Valladolid trials

Trials by the same sponsor.

NCT07302191 — High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women · NA · completed
NCT07307391 — Exercise in Extreme Hot Weather Conditions · NA · completed
NCT06696378 — Melatonin Supplementation and Exercise Program in Breast Cancer Women · NA · recruiting
NCT06616181 — TDCS and Tele-rehabilitation Exercise in Fibromyalgia · NA · not yet recruiting
NCT06326229 — Clinical Validation of Musculoskeletal ICF Core Set in Primary Care Physiotherapy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05712486 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Valladolid
Last refreshed: 25 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05712486.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing